Role of apoptosis for mouse liver growth regulation and tumor promotion: Comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility

Toxicology Letters

Volumn 149, Issue 1-3, 2004, Pages 25-35

  Bursch, W ^a   Grasl Kraupp, B ^a   Wastl, U ^a   Hufnagl, K ^a   Chabicovsky, M ^b   Taper, H ^c   Schulte Hermann, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b IGENEON Immunotherapie of Cancer AG   (Austria)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Apoptosis; C3H He; C57BL 6J; Cell proliferation; Heptocarcinogenesis; Tumor susceptibility

Indexed keywords

NAFENOPIN; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DIET RESTRICTION; DNA CONTENT; GROWTH REGULATION; HISTOPATHOLOGY; HYPERTROPHY; INTERMETHOD COMPARISON; INVOLUTION; LIVER; LIVER CELL; LIVER WEIGHT; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PLOIDY; POLYPLOIDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR CELL; TUMOR PROMOTION;

ADENOMA, LIVER CELL; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; ORGAN SIZE; PRECANCEROUS CONDITIONS;

EID: 1842817567     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.018     Document Type: Conference Paper

References (50)

1. Alden C.L. Safety assessment for non-genotoxic rodent carcinogens: curves, low-dose extrapolations, and mechanisms in carcinogenesis. Hum. Exp. Toxicol. 19(10):2000;557-560.
2. Bannasch, P., Gössner, W., 1994. Pathology of neoplasia and preneoplasia in rodents, In: Bannasch, P., Gössner, W. (Eds.), Schattauer, Stuttgart, New York.
3. Bursch W., Lauer B., Timmermann-Trosiener I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 5(4):1984;453-458.
4. Bursch, W., Fesus, L., Schulte-Hermann, R., 1992. Apoptosis (programmed cell death) and its relevance in liver injury and carcinogenesis, In: Dekant, W., Neumann, H.G. (Eds.), Tissue Specific Toxicology, Academic Press, London, pp. 95-117.
5. Bursch W., Schulte-Hermann R. Synchronization of hepatic DNA synthesis by scheduled feeding and lighting in mice treated with the chemical inducer of liver growth α-hexachlorcyclohexane. Cell Tissue Kinet. 16:1983;125-134.
6. Carter J.H., Carter H.W., Deddens J.A., Hurst B.M., George M.H., DeAngelo A.B. A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F1 mouse given the drinking water chemical dichloroacetic acid. Environ. Health Perspect. 111(1):2003;53-64.
7. Carter J.H., Carter H.W., DeAngelo A.B. Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. Toxicol. Lett. 81(1):1995;55-71.
8. Chabicovsky M., Wastl U., Taper H., Schulte-Hermann R., Bursch W. Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-β1, J. Cancer Res. Clin. Oncol. 129(9):2003;536-542.
9. Christensen J.G., Goldsworthy T.L., Cattley R.C.M. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens. Mol. Carcinog. 25(4):1999;273-284.
10. Diwan B.A., Nims R.W., Lubet R.A., Rice J.M. Liver tumor promoting activity of phenobarbital is associated with its ability to induce phenobarbital-inducible cytochrome(s) P-450 (P-450PB-B), aminopyrine-N- demethylase activity and liver hypertrophy. Toxicologist. 7:1987;106.
11. Fausto, N., 1999. Mouse liver umorigenesis: odels mechanisms and relevance to human disease. Sem. Liver Dis. 19 (3), 243-252, G. Thieme Verlag, Stutlgart, New York.
12. Frey S., Buchmann A., Bursch W., Schulte Hermann R., Schwarz M. Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene. Carcinogenesis. 21:2000;161-166.
13. Gold L.S., Manley N.B., Slone T.H., Ward J.M. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys. Toxicol. Pathol. 29(6):2001;639-652.
14. Goldsworthy T.L., Fransson-Steen R. Quantification of the cancer process in C57Bl/6J, B6C3F1 and C3H/HeJ mice. Toxicol. Pathol. 30(1):2002;97-105.
15. Grasl-Kraupp B., Bursch W., Ruttkay-Nedecky B., Wagner A., Lauer B., Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9995-9999.
16. Grasl-Kraupp B., Ruttkay-Nedecky B., Müllauer L., Taper H., Huber W., Bursch W., Schulte-Hermann R. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology. 25(4):1997;906-912.
17. Hanigan M.H., Winkler M.L., Drinkwater N.R. Induction of three histochemically distinct populations of hepatic foci in C57BL/6J mice. Carcinogenesis. 14(5):1993;1035-1040.
18. Hasmall S.C., Roberts R.A. Hepatic ploidy, nuclearity, and distribution of DNA synthesis: a comparison of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Toxicol. Appl. Pharmacol. 144(2):1997;287-293.
19. Hikita H., Nuwaysir E.F., Vaughan J., Babcock K., Haas M.J., Dragan Y.P., Pitot H.C. The effect of short-term fasting, phenobarbital and refeeding on apoptotic loss, cell replication and gene expression in rat liver during the promotion stage. Carcinogenesis. 19(8):1998;1417-1425.
20. Huber W.W., Grasl-Kraupp B., Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26(4):1996;365-481.
21. James S.J., Muskhelishvili L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6J × C3H F1 mice. Cancer Res. 54:1994;5508-5510.
22. James N.H., Roberts R.A. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis. 17(8):1996;1623-1632.
23. James N.H., Soames A.R., Roberts R.A. Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB). Arch. Toxicol. 72(12):1998;784-790.
24. Kamendulis L.M., Kolaja K.L., Stevenson D.E., Walborg E.F. Jr., Klaunig J.E. Comparative effects of dieldrin on hepatic ploidy, cell proliferation, and apoptosis in rodent liver. J. Toxicol. Environ. Health A. 62(2):2001;127-141.
25. Kolaja K.L., Bunting K.A., Klaunig J.E. Inhibition of tumor promotion and hepatocellular growth by dietary restriction in mice. Carcinogenesis. 17(8):1996a;1657-1664.
26. Kolaja K.L., Stevenson D.E., Walborg E.F. Jr., Klaunig J.E. Selective dieldrin promotion of heptic focal lesions in mice. Carcinogenesis. 17:1996;1243-1250.
27. Kolaja K.L., Stevenson D.E., Walborg E.F. Jr., Klaunig J.E. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis. Carcinogenesis. 17(5):1996c;947-954.
28. Kolaja K.L., Stevenson D.E., Johnson J.T., Walborg E.F. Jr., Klaunig J.E. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fundam. Appl. Toxicol. 29(2):1996d;219-228.
29. Lee G.H. Correlation between Bcl-2 expression and histopathology in diethyl-nitrosamine-induced mouse hepatocellular tumors. Am. J. Pathol. 151(4):1997;957-961.
30. Lee G.H. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis. Toxicol. Pathol. 28(2):2000;215-225.
31. Luebeck G.E., Grasl-Kraupp B., Timmermann-Trosiener I., Bursch W., Schulte-Hermann R., Moolgavkar S.H. Growth kinetics of enzyme altered liver foci in rats treated with phenobarbital or α-hexachlorocylohexane. Toxicol. Appl. Pharmacol. 130:1995;304-315.
32. Luebeck G.E., Buchmann A., Stinchcombe S., Moolgavkar S.H., Schwarz M. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: a quantitative analysis of experimental data using a stochastic model. Toxicol. Appl. Pharmacol. 167(1):2000;63-73.
33. Maronpot R.R., Boorman G.A. The contribution of the mouse in hazard identification studies. Toxicol. Pathol. 24:1996;726-731.
34. Nims R.W., Devor D.E., Henneman J.R., Lubet R.A. Induction of alkoxyresorufin o-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates. Carcinogenesis. 8(1):1987;67-71.
35. Oliver J.D., Roberts R.A. Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis. Pharmacol. Toxicol. 91(1):2002;1-7.
36. Parzefall W., Kainzbauer E., Hong-Min Q., Chabicovsky M., Schulte-Hermann R. Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive mice to signals inducing replication or apoptosis. Arch. Toxicol. 76:2002;699-706.
37. Pereira M.A. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation. Carcinogenesis. 14(2):1993;299-302.
38. Pitot H.C., Hikita H., Dragan Y., Sargent L., Haas M. Review article: the stages of gastrointestinal carcinogenesis - application of rodent models to human disease. Aliment. Pharmacol. Ther. 14(Suppl 1):2000;153-160.
39. Sanders S., Thorgeirsson S.S. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice. Mol. Carcinog. 28(3):2000;168-173.
40. Schulte-Hermann R. Induction of liver growth by xenobiotic compounds and other stimuli. Crit. Rev. Toxicol. 3:1974;97-158.
41. Schulte-Hermann R., Ochs H., Bursch W., Parzefall W. Quantitative structure-activity studies on effects of 16 different steroids on growth and monooxygenases of rat liver. Cancer Res. 48:1988;2462-2468.
42. Schulte-Hermann R., Timmermann-Trosiener I., Barthel G., Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:1990;5127-5135.
43. Schwarz M., Buchmann A., Stinchcombe S., Kalkuhl A., Bock K. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol. Lett. 112-113:2000;69-77.
44. Stevenson D.E., Walborg E.F. Jr., North D.W., Sielken R.L. Jr., Ross C.E., Wright A.S., Xu Y., Kamendulis L.M., Klaunig J.E. Monograph: reassessment of human cancer risk of aldrin/dieldrin. Toxicol. Lett. 109(3):1999;123-186.
45. Tharappel J.C., Lee E.Y., Robertson L.W., Spear B.T., Glauert H.P. Regulation of cell proliferation, apoptosis, and transcription factor activities during the promotion of liver carcinogenesis by polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 179(3):2002;172-184.
46. Tomasi C., Laconi E., Laconi S., Greco M., Sarma D.S., Pani P. Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis. 20(10):1999;1979-1983.
47. Turusov, V.S., Turusov, T.S., 1979. Tumors of the liver, In: Turusov, V.S. (Ed.), Pathology of Tumors in Laboratory Animals. IARC (International Agency for Research on Cancer), Lyon, pp. 193-234.
48. van Ravenzwaay B., Tennekes H. A Wistar rat strain prone to spontaneous liver tumor development: implications for carcinogenic risk assessment. Regul. Toxicol. Pharmacol. 36(1):2002;86-95.
49. Wastl U., Rossmanith W., Lang M.A., Camus-Randon A-M., Grasl-Kraupp B., Bursch W., Schulte-Hermann R. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Mol. Carcinogenesis. 22:1998;229-234.
50. Whysner J., Ross P.M., Williams G.M. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71(1-2):1996;153-191.